Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: A pilot study Academic Article uri icon

Overview

MeSH Major

  • Amifostine
  • Proctitis
  • Prostatic Neoplasms
  • Radiation Injuries
  • Radiation-Protective Agents
  • Rectum

abstract

  • This trial suggests greater rectal radioprotection from acute effects with 2 g vs. 1 g amifostine suspension. Further studies should be conducted in populations at higher risk for developing symptomatic acute and late proctitis.

publication date

  • July 15, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2006.02.030

PubMed ID

  • 16730138

Additional Document Info

start page

  • 1008

end page

  • 13

volume

  • 65

number

  • 4